Composition comprises at least one mucus drug and/or its extract and polidocanol as local anesthetic. ACTIVITY : Antiinflammatory

The invention relates to medicine, in particular to surgery and may be used for the endovascular treatment of varicose disease.According to the invention, the claimed method consists in that is carried out the local anesthesia, then is performed the puncture of great or small saphenous vein under ultrasonic guidance, into the lumen of the vein is introduced the guide and the catheter with optical fiber connected to a laser radiation generator at a distance of 1.5...2.0 cm from the anastomosis of...

This invention relates to a composition comprising a chaotropic agent, a buffering substance, and 0.5 to 5% (V/V) polidocanol or a derivative thereof. The invention is further related to uses of this composition and to a kit comprising the composition according to the invention. The invention is further related to a method for the detection of a nucleic acid in a biological sample comprising the steps of incubating the biological sample in the presence of a chaotropic agent, a buffering substanc...

The invention relates to compositions containing nanoparticles and to uses o f said compositions for encapsulating therapeutically active substances in cel ls by means of nanoparticles with a particular coating. The particles are chemically formed in such a way as to enable a high intracellular absorption into the cells. The encapsulation requires no direct binding between nanoparticles and the therapeutically active substance. The encapsulation enables an increased efficiency of the substance w...

Preliminary injection of polidocanol microfoam (I) in laser-based therapy of varices comprises initial intravenous injection of a hypermolar hydroalcoholic agent injection of (I) and application of a Nd-Yag laser emitting at its fundamental wavelength or another laser emitting at a wavelength approaching the resonance of the polydocanol

A talmy olyan polidocanol tartalmgyyszerkzmyellla vonatkozik mellyel nty eml - idetve az embertis - m petevezeteit lehet kezelni. Rzletesebben atalmy a polidocanolnak a petevezetek elza /vagyrendellenes mvz illetve cyst kezele alkalmasgyyszerkzmyek ellla vonatkozik a fent emlettegyedekben betegekben.

The invention concerns Th. use of polidocanol for the preparation of a pharmaceutical composition for the treatment of the uterine and the fallopian tube of a female mammal including human. More specifically the invention concerns the use of polidocanol for the occlusion of the fallopian tubes and/or for the treatment of functional endometrial bleeding and cysts of said subjects and patients. The invention includes the methods of said non-surgical treatments.